Create a proposal for your Design for Change Capstone Project. Open the template in Doc Sharing. You will include the information from Milestone #1, your PICO question, and evidence appraisal, as you compose this proposal.
Your plan is to convince your management team of a nursing problem you have uncovered and you feel is significant enough to change the way something is currently practiced.
2. The format for this proposal will be a paper following the Publication manual of APA 6th edition.
3. The paper is to be four- to six-pages excluding the Title page and Reference page.
4. As you organize your information and evidence, include the following topics.
a. Introduction: Write an introduction but do not use Introduction as a heading in accordance with the rules put forth in the Publication manual of the American Psychological Association (2010, p. 63). Introduce the reader to the plan with evidence-based problem identification and solution.
b. Change Plan: Write an overview using the Johns Hopkins Nursing EBP Model and Guidelines (2012)
i. Practice Question
ii. Evidence
iii. Translation
c. Summary
5. Citations and References must be included to support the information within each topic area. Refer to the APA manual, Chapter 7, for examples of proper reference format. In-text citations are to be noted for all information contained in your paper that is not your original idea or thought. Ask yourself, How do I know this? and then cite the source. Scholarly sources are expected, which means using peer-reviewed journals and credible websites.
6. Tables and Figures may be added as appropriate to the project. They should be embedded within the body of the paper (see your APA manual for how to format and cite). Creating tables and figures offers visual aids to the reader and enhances understanding of your literature review and design for change.
PICOT Question-If patients diagnosed with cancer who are being treated with an oral EGFR inhibitor (P), are treated prophylactically with over the counter skin moisturizers (I), compared to those who are treated at the time of onset of skin irritation (C), will there be less severity of skin irritation (O) over a period of one month (T)?
References :https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644628/
Perez-Soler, R., Delord, J. P., Halpern, A., Kelly, K., Krueger, J., Sureda, B. M., Leyden, J.
(2005). HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation
Outcomes from the HER1/EGFR Inhibitor Rash Management Forum. The Oncologist, 10(5), 345-356.
https://dx.doi.org/10.1634/theoncologist.10-5-345
https://theoncologist.alphamedpress.org/content/10/5/345.long
Gerber, P. A., Meller, S., Eames, T., Buhren, B. A., Schrumpf, H., Hetzer, S., . . . Homey, B.
(2012). Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.
European Journal of Medical Research, 17(4). https://dx.doi.org/10.1186/2047-783X-17-4
PLACE THIS ORDER OR A SIMILAR ORDER WITH NURSING HOMEWORK HELP TODAY AND GET AN AMAZING DISCOUNT
